Related Experiment Video
Updated: May 1, 2026

10:54
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
1.1K
Depression treated by homeopaths: a study protocol for a pragmatic cohort multiple randomised controlled trial
Petter Viksveen1, Clare Relton1
1School of Health and Related Research, University of Sheffield, UK.
Homeopathy : the Journal of the Faculty of Homeopathy
|April 2, 2014
Summary
This study evaluates the effectiveness of homeopathic treatment as an add-on therapy for depression. It assesses patient acceptance and compares clinical and cost-effectiveness against standard care for depression.
Area of Science:
- Integrative medicine
- Mental health research
- Clinical trial methodology
Background:
- Standard depression treatments (psychotherapy, antidepressants) are not used by 38% of patients.
- Homeopathic treatment for depression lacks sufficient evidence regarding effectiveness, cost-effectiveness, and safety.
- A significant portion of the population reports long-term depression, necessitating exploration of alternative or adjunctive therapies.
Purpose of the Study:
- To evaluate the acceptability of adjunctive homeopathic treatment for self-reported depression.
- To compare the clinical and cost-effectiveness of offering homeopathic treatment versus no offer.
- To assess the safety and patient-reported outcomes of homeopathic interventions in a real-world setting.
Main Methods:
- Pragmatic randomized controlled trial within the South Yorkshire Cohort (SYC).
- 162 participants randomly assigned to receive an offer of homeopathic treatment.
- Primary outcome measured by PHQ-9, with intention-to-treat (ITT) and complier average causal effect (CACE) analyses at 6 and 12 months.
- Cost-effectiveness analysis using quality-adjusted life year (QALY).
- Qualitative interviews with up to 30 patients for in-depth understanding.
- Thematic analysis of qualitative data, triangulated with quantitative findings.
Main Results:
- The study is designed to compare outcomes between the offer and no offer groups.
- Analysis will determine the comparative effectiveness and cost-effectiveness of adjunctive homeopathic treatment.
- Qualitative data will provide insights into patient experiences and treatment acceptability.
Conclusions:
- The trial aims to provide evidence on the role of homeopathy as an adjunctive therapy for depression.
- Findings will inform patients and healthcare providers about the potential benefits and drawbacks of homeopathic treatment for depression.
- This research contributes to understanding patient preferences and the integration of complementary therapies in mental healthcare.
Keywords:
Cohort multiple randomised controlled trialCost-effectivenessDepressionEffectivenessHomeopathyMixed methodQualitative studyMore Related Videos
Related Concept Videos
The Placebo Effect
5.9K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
5.9K
Long-term Depression
27.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
27.3K
Depressive Disorders: MDD and Dysthymia
1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K

